Zoledronic acid reduces bone loss in men with prostate cancer receiving goserelin
R. Casey, W. Love, C. Mendoza, D. Reymond, M. ZarendaVolume:
38
Year:
2006
Language:
english
DOI:
10.1016/j.bone.2006.01.018
File:
PDF, 51 KB
english, 2006